Article Details

Roche to Acquire CAR-T Cell Therapy Candidate for Possible Use for MS in Poseida Merger Deal

Retrieved on: 2024-12-09 21:16:02

Tags for this article:

Click the tags to see associated articles and topics

Roche to Acquire CAR-T Cell Therapy Candidate for Possible Use for MS in Poseida Merger Deal. View article details on hiswai:

Excerpt

Swiss pharmaceutical company Roche has announced plans to acquire clinical-stage biopharmaceutical company Poseida Therapeutics based in San Diego ...

Article found on: www.managedhealthcareexecutive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo